Study | Country | Study design | Number of patients | Group | Location | NOS score (star rating) | ||
---|---|---|---|---|---|---|---|---|
D | P | Left | Right | |||||
Bu L. [6] | China | CCT | 72 | 33 | 39 | 27 | 45 | ****** |
Guo H [9]. | China | CCT | 69 | 36 | 33 | None | 69 | ***** |
Ji LL [10]. | China | CCT | 100 | 50 | 50 | 37 | 63 | ***** |
Kim DH [11]. | Korea | CCT | 52 | 31 | 21 | None | 52 | ******* |
Matsuoka, H [12]. | Japan | RCT | 35 | 17 | 18 | 12 | 23 | _ |
Qi HF [13]. | China | RCT | 100 | 50 | 50 | None | 100 | _ |
Seok Y [7]. | Korea | CCT | 72 | 43 | 29 | 34 | 38 | ****** |
Wang WH [14]. | China | RCT | 110 | 55 | 55 | 56 | 54 | _ |